The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.

International Journal of Oncology
N FortunatiG Boccuzzi

Abstract

Triple-negative breast cancer (TNBC) is a very aggressive type of tumour and its aggressiveness is linked to E-cadherin downregulation. In estrogen-sensitive breast cancer, high levels of E-cadherin fit with high levels of ERα and MTA3 (a component of the transcription Mi-2/NuRD complex with intrinsic DAC activity). In TNBC the E-cadherin downregulation could be due to epigenetic silencing of the CDH1 gene as well as to the lack of a fully functioning ERα-activated pathway. We report that the pan-histone deacetylase inhibitor LBH589, a potent anti-proliferative agent, induced E-cadherin expression on cell membranes of MDA-MB-231 cells (TNBC), determining a reduction of cell invasion and migration. Even though E-cadherin expression in breast cancer is also regulated by estradiol and the ERα/MTA3/Snail/Slug pathway, LBH589 is able to increase E-cadherin without affecting the estrogen pathway. In fact, no expression of ERα, PR and FoxA1 was observed in MDA-MB-231 cells before and after LBH589 treatment; furthermore, the drug caused an increase in Snail and Slug expression with a concomitant reduction of MTA3 levels. Taking into consideration its anti-proliferative and anti-invasive properties, we suggest the use of LBH589 in aggre...Continue Reading

References

Nov 5, 2002·The American Journal of Pathology·Erika RosivatzKarl-Friedrich Becker
Mar 31, 2004·Seminars in Oncology·Benita S Katzenellenbogen, Jonna Frasor
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Oct 28, 2005·The New England Journal of Medicine·Donald A BerryUNKNOWN Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Nov 13, 2007·Advances in Experimental Medicine and Biology·Ana Maria Gonzalez-AnguloGabriel N Hortobagyi
Nov 17, 2007·Cancer Letters·Nicoletta FortunatiGiuseppe Boccuzzi
May 13, 2008·Mutation Research·Carla SawanZdenko Herceg
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bryan P SchneiderLisa A Carey
Mar 31, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·In Ah KimEric J Bernhard
Jun 11, 2009·Molecular Cancer Therapeutics·Leigh EllisRicky W Johnstone
Aug 7, 2009·Journal of the National Cancer Institute·Fatima CardosoUNKNOWN ESO-MBC Task Force
Sep 24, 2009·Molecular and Cellular Endocrinology·N FortunatiG Boccuzzi
Dec 16, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Serena T Wong
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Dec 22, 2009·American Journal of Clinical Oncology·Anthony D Elias
Feb 4, 2010·International Journal of Cancer. Journal International Du Cancer·Wenlin ShaoPeter Atadja
Jul 16, 2010·Molecular Oncology·Jovana JovanovicVessela Kristensen
Mar 10, 2011·Nature Medicine·Manuel Rodríguez-Paredes, Manel Esteller
Mar 15, 2011·International Journal of Cancer. Journal International Du Cancer·Maria Graziella CatalanoGiuseppe Boccuzzi
May 23, 2012·Breast Cancer Research : BCR·Chandra R TateBridgette M Collins-Burow

❮ Previous
Next ❯

Citations

Nov 18, 2017·BMC Biology·Sara Sannino, Jeffrey L Brodsky
Aug 14, 2019·Bioorganic Chemistry·Meiling HuangRui Ling
Apr 20, 2021·Life Sciences·M Janaki RamaiahRajasekhar Reddy Manyam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.